Andrew Li

3.9k total citations · 3 hit papers
41 papers, 2.6k citations indexed

About

Andrew Li is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Biomedical Engineering. According to data from OpenAlex, Andrew Li has authored 41 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Epidemiology and 9 papers in Biomedical Engineering. Recurrent topics in Andrew Li's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Nanoparticle-Based Drug Delivery (4 papers). Andrew Li is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Nanoparticle-Based Drug Delivery (4 papers). Andrew Li collaborates with scholars based in Singapore, United States and China. Andrew Li's co-authors include Lang Rao, Wei Liu, Shishang Guo, Zhi‐Jun Sun, Lin‐Lin Bu, Wen‐Feng Zhang, Bo Cai, Tza‐Huei Wang, Xingzhong Zhao and Junhua Xu and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Andrew Li

39 papers receiving 2.6k citations

Hit Papers

Cancer Cell Membrane‐Coated Upconversion Nanoprobes for H... 2015 2026 2018 2022 2016 2015 2020 100 200 300 400

Peers

Andrew Li
Jonathan A. Copp United States
Jiarong Zhou United States
Todd D. Giorgio United States
Dmitri Simberg United States
Evan A. Scott United States
Richard Tsai United States
Ben Ouyang Canada
Jonathan A. Copp United States
Andrew Li
Citations per year, relative to Andrew Li Andrew Li (= 1×) peers Jonathan A. Copp

Countries citing papers authored by Andrew Li

Since Specialization
Citations

This map shows the geographic impact of Andrew Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Li more than expected).

Fields of papers citing papers by Andrew Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Li. The network helps show where Andrew Li may publish in the future.

Co-authorship network of co-authors of Andrew Li

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Li. A scholar is included among the top collaborators of Andrew Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Li. Andrew Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Andrew, Ping Yee Billie Au, Jennifer Bain, et al.. (2025). Expanding the Phenotypic Spectrum of HNRNPU‐Related Disorder, Documenting the First Familial Presentation and Comprehensive Review. American Journal of Medical Genetics Part A. 197(6). e64013–e64013. 2 indexed citations
2.
Liu, Jun, et al.. (2024). Rapid production of COVID-19 subunit vaccine candidates and their immunogenicity evaluation in pigs. International Journal of Biological Macromolecules. 272(Pt 1). 132798–132798. 1 indexed citations
3.
Xiong, Haocheng, Haonan Li, Andrew Li, et al.. (2024). CO2-mediated bicarbonate conversion to concentrated formate in a CEM-based electrolyzer. Journal of Energy Chemistry. 100. 605–611. 4 indexed citations
4.
Ng, Dorothy Hui Lin, Barnaby Edward Young, Sapna P. Sadarangani, et al.. (2024). Study protocol: infectious diseases consortium (I3D) for study on integrated and innovative approaches for management of respiratory infections: respiratory infections research and outcome study (RESPIRO). BMC Infectious Diseases. 24(1). 123–123. 4 indexed citations
5.
Cai, Yiying, Andrew Li, Paul Anantharajah Tambyah, et al.. (2024). Cost-effectiveness of a short-course antibiotic treatment strategy for the treatment of ventilator-associated pneumonia: an economic analysis of the REGARD-VAP trial. The Lancet Global Health. 12(12). e2059–e2067.
6.
Shukeri, Wan Fadzlina Wan Muhd, et al.. (2023). Prevalence and Outcome of Sepsis: Mortality and Prolonged Intensive Care Unit Stay among Sepsis Patients Admitted to a Tertiary Centre in Malaysia. Malaysian Journal of Medical Sciences. 30(6). 120–132. 4 indexed citations
7.
Sunshine, Sarah B., et al.. (2023). 383 A Pilot Study of Tear Cytokine Profiling in a Patient with Ocular Graft versus Host Disease. Journal of Clinical and Translational Science. 7(s1). 113–114. 1 indexed citations
8.
Yu, Qing, Heng Su, Andrew Li, et al.. (2023). Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells. International Journal of Medical Sciences. 20(10). 1282–1292. 2 indexed citations
9.
Li, Andrew & Pyng Lee. (2022). Which Endoscopic Procedure to Use and in What Patient? Valves, Coils, Foam, and Heat in COPD and Asthma. Pulmonary Therapy. 9(1). 49–69. 3 indexed citations
10.
Mo, Yin, T. Eoin West, Graeme MacLaren, et al.. (2021). Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial. BMJ Open. 11(5). e050105–e050105. 8 indexed citations
11.
Li, Andrew, et al.. (2021). Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma. The Korean Journal of Internal Medicine. 36(6). 1305–1319. 8 indexed citations
12.
Rao, Lang, Lei Wu, Zhida Liu, et al.. (2020). Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nature Communications. 11(1). 4909–4909. 307 indexed citations breakdown →
13.
Li, Andrew, et al.. (2020). A diver’s dilemma – a case report on bronchopulmonary sequestration. BMC Pulmonary Medicine. 20(1). 121–121. 4 indexed citations
14.
Ma, Weijie, Daoming Zhu, Jinghua Li, et al.. (2020). Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment. Theranostics. 10(3). 1281–1295. 185 indexed citations
15.
Li, Andrew & Amartya Mukhopadhyay. (2020). Substrate utilization and energy expenditure pattern in sepsis by indirect calorimetry. Critical Care. 24(1). 535–535. 10 indexed citations
16.
Li, Andrew, et al.. (2019). <p>Improving Influenza Vaccination Coverage Among Patients With COPD: A Pilot Project</p>. International Journal of COPD. Volume 14. 2527–2533. 17 indexed citations
17.
Rao, Lang, Qian‐Fang Meng, Qinqin Huang, et al.. (2018). Platelet–Leukocyte Hybrid Membrane‐Coated Immunomagnetic Beads for Highly Efficient and Highly Specific Isolation of Circulating Tumor Cells. Advanced Functional Materials. 28(34). 208 indexed citations
18.
Rao, Lang, Wenbiao Wang, Qian‐Fang Meng, et al.. (2018). A Biomimetic Nanodecoy Traps Zika Virus To Prevent Viral Infection and Fetal Microcephaly Development. Nano Letters. 19(4). 2215–2222. 66 indexed citations
19.
Rao, Lang, Qian‐Fang Meng, Lin‐Lin Bu, et al.. (2017). Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging. ACS Applied Materials & Interfaces. 9(3). 2159–2168. 215 indexed citations
20.
Li, Andrew, et al.. (2013). Capnocytophaga sputigena Empyema. Journal of Clinical Microbiology. 51(8). 2772–2774. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026